Home » Authors » Donna Young

Articles by Donna Young

Amgen's Woes Disrupt Plans For $1 Billion Plant In Ireland

Oct. 5, 2007

Amgen's Woes Disrupt Plans For $1 Billion Plant In Ireland

Oct. 5, 2007

Alethia, Canadian Agency In Deal For Cancer Targeting

Oct. 4, 2007

Alethia Biotherapeutics Inc. has entered into a licensing agreement with Canada's National Research Council Biotechnology Research Institute (NRC-BRI) for the worldwide therapeutic and diagnostic rights to Clusterin-specific antibodies. (BioWorld Today)

Alethia, Canadian Agency In Deal For Cancer Targeting

Oct. 4, 2007

Alethia Biotherapeutics Inc. has entered into a licensing agreement with Canada's National Research Council Biotechnology Research Institute (NRC-BRI) for the worldwide therapeutic and diagnostic rights to Clusterin-specific antibodies. (BioWorld Today)

Axcan, Cellerix Deal For Adult Stem Cell Therapy

Oct. 3, 2007

Axcan, Cellerix Deal For Adult Stem Cell Therapy

Oct. 3, 2007

House Passes Bill Called Vital to Free SBIR Money for Biotech

Oct. 2, 2007

Theratechnologies Reports Strong Results For TH9507

Oct. 2, 2007

Theratechnologies Reports Strong Results For TH9507

Oct. 2, 2007

House Passes Bill Called Vital to Free SBIR Money for Biotech

Oct. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...